Skip to main content
Top
Published in: Clinical and Translational Oncology 5/2014

01-05-2014 | Special Article

Infrastructures, treatment modalities, and workload of radiation oncology departments in Spain with special attention to prostate cancer

Authors: J. López Torrecilla, A. Zapatero, I. Herruzo, F. A. Calvo, M. A. Cabeza, A. Palacios, A. Guerrero, A. Hervás, P. Lara, B. Ludeña Martínez, E. del Cerro Peñalver, G. Nagore, G. Sancho, J. L. Mengual, M. Mira, A. Mairiño, P. Samper, S. Pérez, I. Castillo, J. C. Martínez Cedrés, E. Ferrer, S. Rodriguez, X. Maldonado, A. Gómez Caamaño, C. Ferrer, On behalf of the Grupo de Investigación GICOR-URONCOR-SEOR

Published in: Clinical and Translational Oncology | Issue 5/2014

Login to get access

Abstract

Aim

The purpose of the study was to describe infrastructures, treatment modalities, and workload in radiation oncology (RO) in Spain, referred particularly to prostate cancer (PC).

Methods

An epidemiologic, cross-sectional study was performed during 2008–2009. A study-specific questionnaire was sent to the 108 RO-registered departments.

Results

One hundred and two departments answered the survey, and six were contacted by telephone. Centers operated 236 treatment units: 23 (9.7 %) cobalt machines, 37 (15.7 %) mono-energetic linear accelerators, and 176 (74.6 %) multi-energy linear accelerators. Sixty-one (56.4 %) and 33 (30.5 %) departments, respectively, reported intensity-modulated radiation therapy (IMRT) and image-guided RT (IGRT) capabilities; three-dimensional-conformal RT was used in 75.8 % of patients. Virtual simulators were present in 95 departments (88.0 %), 35 use conventional simulators. Fifty-one departments (47.2 %) have brachytherapy units, 38 (35.2 %) perform prostatic implants. Departments saw a mean of 24.9 new patients/week; the number of patients treated annually was 102,054, corresponding to 88.4 % of patients with a RT indication. In 56.5 % of the hospitals, multidisciplinary teams were available to treat PC.

Conclusions

Results provide an accurate picture of current situation of RO in Spain, showing a trend toward the progressive introduction of new technologies (IMRT, IGRT, brachytherapy).
Appendix
Available only for authorised users
Literature
1.
go back to reference Comisión de las Sociedades Oncológicas para la Planificación Oncológica en España Libro Blanco de la Oncología en España. Informe para la Planificación global de la Oncología. Ed. Jims, Barcelona; 1988. Comisión de las Sociedades Oncológicas para la Planificación Oncológica en España Libro Blanco de la Oncología en España. Informe para la Planificación global de la Oncología. Ed. Jims, Barcelona; 1988.
2.
go back to reference López-Torrecilla J, Guedea F, Heeren G, Nissin R, Ellison T, Cottier B. Patterns of care for brachytherapy in Europe. Results in Spain. Clin Transl Oncol. 2006;8(5):362–8.PubMedCrossRef López-Torrecilla J, Guedea F, Heeren G, Nissin R, Ellison T, Cottier B. Patterns of care for brachytherapy in Europe. Results in Spain. Clin Transl Oncol. 2006;8(5):362–8.PubMedCrossRef
3.
go back to reference Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18(3):581–92.PubMedCrossRef Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18(3):581–92.PubMedCrossRef
4.
go back to reference Zapatero A, López-Torrecilla J, Herruzo I, Calvo FA, SEOR URONCOR GICOR participating Investigators. Practice patterns in the management of prostate cancer in Spain: results from a national survey among radiation oncologists in 2009. Clin Transl Oncol. 2013;15(3):226–32.PubMedCrossRef Zapatero A, López-Torrecilla J, Herruzo I, Calvo FA, SEOR URONCOR GICOR participating Investigators. Practice patterns in the management of prostate cancer in Spain: results from a national survey among radiation oncologists in 2009. Clin Transl Oncol. 2013;15(3):226–32.PubMedCrossRef
5.
go back to reference Zapatero A, Valcarcel F, Calvo FA, Alga’s R, Béjar A, Maldonado J, et al. Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study. J Clin Oncol. 2005;23(27):6561–8.PubMedCrossRef Zapatero A, Valcarcel F, Calvo FA, Alga’s R, Béjar A, Maldonado J, et al. Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study. J Clin Oncol. 2005;23(27):6561–8.PubMedCrossRef
6.
go back to reference Slotman BJ, Cottier B, Bentzen SM, Heeren G, Lievens Y, van den Bogaert W. Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO-QUARTS: workpackage 1. Radiother Oncol. 2005;75(3):349–54.PubMedCrossRef Slotman BJ, Cottier B, Bentzen SM, Heeren G, Lievens Y, van den Bogaert W. Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO-QUARTS: workpackage 1. Radiother Oncol. 2005;75(3):349–54.PubMedCrossRef
7.
go back to reference Porter A, Aref A, Chodounsky Z, Elzawawy A, Manatrakul N, Ngoma T, et al. A global strategy for radiotherapy: a WHO consultation. Clin Oncol (R Coll Radiol). 1999;11:368–70. Porter A, Aref A, Chodounsky Z, Elzawawy A, Manatrakul N, Ngoma T, et al. A global strategy for radiotherapy: a WHO consultation. Clin Oncol (R Coll Radiol). 1999;11:368–70.
8.
go back to reference Herruzo Cabrera I, Espinosa Calvo M, López-Torrecilla J, Maciá Garau M, Palacios Eito A, Sánchez Calzado J, et al. Cálculo de necesidades e infraestructura en España. In: Libro Blanco SEOR-XXI. Análisis de la situación, necesidades y recursos de la Oncología Radioterápica. Editores Médicos, SA. EDIMSA, Madrid; 2010;65–85. Herruzo Cabrera I, Espinosa Calvo M, López-Torrecilla J, Maciá Garau M, Palacios Eito A, Sánchez Calzado J, et al. Cálculo de necesidades e infraestructura en España. In: Libro Blanco SEOR-XXI. Análisis de la situación, necesidades y recursos de la Oncología Radioterápica. Editores Médicos, SA. EDIMSA, Madrid; 2010;65–85.
9.
go back to reference Martínez García C, Sánchez Pérez MJ, Borrás-i-Andrés JM. El Cáncer en España: Epidemiología descriptiva in: Libro Blanco SEOR-XXI. Análisis de la situación, necesidades y recursos de la Oncología Radioterápica. Editores Médicos, SA. EDIMSA. Madrid; 2010;9–40. Martínez García C, Sánchez Pérez MJ, Borrás-i-Andrés JM. El Cáncer en España: Epidemiología descriptiva in: Libro Blanco SEOR-XXI. Análisis de la situación, necesidades y recursos de la Oncología Radioterápica. Editores Médicos, SA. EDIMSA. Madrid; 2010;9–40.
10.
go back to reference Cortes F, Díaz R, García V, Herranz C, Martinez C, Muñoz Villa A, et al. Segundo Libro Blanco de la Oncología Española. ENE Publicidad; Madrid; 1995. Cortes F, Díaz R, García V, Herranz C, Martinez C, Muñoz Villa A, et al. Segundo Libro Blanco de la Oncología Española. ENE Publicidad; Madrid; 1995.
11.
go back to reference Palacios Eito A, Espinosa Calvo M, Mañas Rueda A, de las Heras González M. Equipamiento y necesidades futuras. Situación actual en España. Revisiones en Cáncer 2006;20(5):205–12. Palacios Eito A, Espinosa Calvo M, Mañas Rueda A, de las Heras González M. Equipamiento y necesidades futuras. Situación actual en España. Revisiones en Cáncer 2006;20(5):205–12.
12.
go back to reference Esco R, Palacios A, Pardo J, Biete A, Carceller JA, Veiras C, et al. Infrastructure of radiotherapy in Spain: a minimal standard of radiotherapy resources. Int J Radiat Oncol Biol Phys. 2003;56(2):319–27.PubMedCrossRef Esco R, Palacios A, Pardo J, Biete A, Carceller JA, Veiras C, et al. Infrastructure of radiotherapy in Spain: a minimal standard of radiotherapy resources. Int J Radiat Oncol Biol Phys. 2003;56(2):319–27.PubMedCrossRef
13.
go back to reference Larrañaga N, Galceran J, Ardanaz E, Franch P, Sánchez MJ, Pastor-Barriuso R, et al. Prostate cancer incidence trends in Spain before and during the prostate-specific antigen era: impact on mortality. Ann Oncol. 2010;21(Suppl 3):iii83–9. Larrañaga N, Galceran J, Ardanaz E, Franch P, Sánchez MJ, Pastor-Barriuso R, et al. Prostate cancer incidence trends in Spain before and during the prostate-specific antigen era: impact on mortality. Ann Oncol. 2010;21(Suppl 3):iii83–9.
14.
go back to reference Guedea F, Venselaar J, Hoskin P, Hellebust TP, Peiffert D, Londres B, et al. Patterns of care for brachytherapy in Europe: updated results. Radiother Oncol. 2010;97(3):514–20.PubMedCrossRef Guedea F, Venselaar J, Hoskin P, Hellebust TP, Peiffert D, Londres B, et al. Patterns of care for brachytherapy in Europe: updated results. Radiother Oncol. 2010;97(3):514–20.PubMedCrossRef
15.
go back to reference Ruggieri-Pignon S, Pignon T, Marty M, Rodde-Dunet MH, Destembert B, Fritsch B. Infrastructure of radiation oncology in France: a large survey of evolution of external beam radiotherapy practice. Int J Radiat Oncol Biol Phys. 2005;61(2):507–16.PubMedCrossRef Ruggieri-Pignon S, Pignon T, Marty M, Rodde-Dunet MH, Destembert B, Fritsch B. Infrastructure of radiation oncology in France: a large survey of evolution of external beam radiotherapy practice. Int J Radiat Oncol Biol Phys. 2005;61(2):507–16.PubMedCrossRef
16.
go back to reference Jetne V, Kvaløy S, Smeland S, Johannesen TB, Tveit KM. Use of radiotherapy in South-Eastern Norway Regional Health Authority. Tidsskr Nor Laegeforen. 2009 17;129(24):2602–5. Jetne V, Kvaløy S, Smeland S, Johannesen TB, Tveit KM. Use of radiotherapy in South-Eastern Norway Regional Health Authority. Tidsskr Nor Laegeforen. 2009 17;129(24):2602–5.
17.
go back to reference Ringborg U, Bergqvist D, Brorsson B, Cavallin-Ståhl E, Ceberg J, Einhorn N, et al. The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of radiotherapy for cancer including a prospective survey of radiotherapy practice in Sweden 2001—summary and conclusions. Acta Oncol. 2003;42(5–6):357–65.PubMedCrossRef Ringborg U, Bergqvist D, Brorsson B, Cavallin-Ståhl E, Ceberg J, Einhorn N, et al. The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of radiotherapy for cancer including a prospective survey of radiotherapy practice in Sweden 2001—summary and conclusions. Acta Oncol. 2003;42(5–6):357–65.PubMedCrossRef
18.
go back to reference Delaney GP, Jacob S, Featherstone C, Barton M. Radiotherapy in cancer care: estimating optimal utilisation from a review of evidence-based clinical guidelines. Collaboration for Cancer Outcomes Research and Evaluation (CCORE). Liverpool Hospital; Sydney; 2003. Delaney GP, Jacob S, Featherstone C, Barton M. Radiotherapy in cancer care: estimating optimal utilisation from a review of evidence-based clinical guidelines. Collaboration for Cancer Outcomes Research and Evaluation (CCORE). Liverpool Hospital; Sydney; 2003.
19.
go back to reference Tyldesley S, Delaney G, Foroudi F, Barbera L, Kerba M, Mackillop W. Estimating the need for radiotherapy for patients with prostate, breast, and lung cancers: verification of model estimates of need with radiotherapy utilization data from British Columbia. Int J Radiat Oncol Biol Phys. 2011;79(5):1507–15.PubMedCrossRef Tyldesley S, Delaney G, Foroudi F, Barbera L, Kerba M, Mackillop W. Estimating the need for radiotherapy for patients with prostate, breast, and lung cancers: verification of model estimates of need with radiotherapy utilization data from British Columbia. Int J Radiat Oncol Biol Phys. 2011;79(5):1507–15.PubMedCrossRef
20.
go back to reference Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. Cancer incidence in five continents, Vol. IX. IARC Scientific Publications No 160, Lyon: IARC, 2007 Board of the Faculty of Clinical Oncology. Equipment, workload and staffing for radiotherapy in the UK 1997–2002. London: The Royal College of Radiologists; 2003. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. Cancer incidence in five continents, Vol. IX. IARC Scientific Publications No 160, Lyon: IARC, 2007 Board of the Faculty of Clinical Oncology. Equipment, workload and staffing for radiotherapy in the UK 1997–2002. London: The Royal College of Radiologists; 2003.
Metadata
Title
Infrastructures, treatment modalities, and workload of radiation oncology departments in Spain with special attention to prostate cancer
Authors
J. López Torrecilla
A. Zapatero
I. Herruzo
F. A. Calvo
M. A. Cabeza
A. Palacios
A. Guerrero
A. Hervás
P. Lara
B. Ludeña Martínez
E. del Cerro Peñalver
G. Nagore
G. Sancho
J. L. Mengual
M. Mira
A. Mairiño
P. Samper
S. Pérez
I. Castillo
J. C. Martínez Cedrés
E. Ferrer
S. Rodriguez
X. Maldonado
A. Gómez Caamaño
C. Ferrer
On behalf of the Grupo de Investigación GICOR-URONCOR-SEOR
Publication date
01-05-2014
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 5/2014
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-013-1121-2

Other articles of this Issue 5/2014

Clinical and Translational Oncology 5/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine